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Abstract
Background: Prior studies have shown insulin resistance is associated with reduced cardiac autonomic function
measured at rest, but few studies have determined whether insulin resistance is associated with reduced cardiac
autonomic function measured during daily activities.
Methods: We examined older adults without diabetes with 48-h ambulatory electrocardiography (n = 759) in an
ancillary study of the Atherosclerosis Risk in Communities Study. Insulin resistance, the exposure, was defined by
quartiles for three indexes: 1) the homeostatic model assessment of insulin resistance (HOMA-IR), 2) the triglyceride
and glucose index (TyG), and 3) the triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C). Low heart
rate variability, the outcome, was defined by <25th percentile for four measures: 1) standard deviation of normal-to-
normal R-R intervals (SDNN), a measure of total variability; 2) root mean square of successive differences in normal-
to-normal R-R intervals (RMSSD), a measure of vagal activity; 3) low frequency spectral component (LF), a measure
of sympathetic and vagal activity; and 4) high frequency spectral component (HF), a measure of vagal activity.
Logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals weighted for sampling/non-
response, adjusted for age at ancillary visit, sex, and race/study-site. Insulin resistance quartiles 4, 3, and 2 were
compared to quartile 1; high indexes refer to quartile 4 versus quartile 1.
Results: The average age was 78 years, 66% (n = 497) were women, and 58% (n = 438) were African American.
Estimates of association were not robust at all levels of HOMA-IR, TyG, and TG/HDL-C, but suggest that high
indexes were associated consistently with indicators of vagal activity. High HOMA-IR, high TyG, and high TG/HDL-C
were consistently associated with low RMSSD (OR: 1.68 (1.00, 2.81), OR: 2.03 (1.21, 3.39), and OR: 1.73 (1.01, 2.91),
respectively). High HOMA-IR, high TyG, and high TG/HDL-C were consistently associated with low HF (OR: 1.90 (1.14,
3.18), OR: 1.98 (1.21, 3.25), and OR: 1.76 (1.07, 2.90), respectively).
Conclusions: In older adults without diabetes, insulin resistance was associated with reduced cardiac autonomic
function – specifically and consistently for indicators of vagal activity – measured during daily activities. Primary
prevention of insulin resistance may reduce the related risk of cardiac autonomic dysfunction.
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Background
Insulin resistance is a condition defined by a reduced re-
sponse to insulin in target tissues [1]. It often precedes
the development of the metabolic dysregulations and
metabolic disorders that contribute to an increase in risk
for cardiovascular disease [2–5]. However, insulin resist-
ance is modifiable [6], making it an important target for
primary prevention of cardiovascular risk.
Insulin resistance may contribute to cardiovascular
risk attributed, in part, to its effect on cardiac autonomic
function [7] that can be measured non-invasively with
heart rate variability [8] and has been shown to be asso-
ciated with a higher incidence of cardiovascular events
[9]. Prior studies have shown that adults with diabetes
have lower heart rate variability [10–12]. Furthermore,
among adults without diabetes, heart rate variability is
lower in adults with elevated insulin levels [10–12]. This
evidence is based on shorter-term electrocardiogram re-
cordings measured at rest. There is a limited understand-
ing based on longer-term electrocardiogram recordings
measured during daily activities.
Insulin resistance can be measured using insulin resist-
ance indexes that are less invasive than standard reference
measures [13] and represent other aspects of insulin re-
sistance, such as hepatic insulin resistance and peripheral
insulin resistance. They include the homeostatic model
assessment of insulin resistance (HOMA-IR) [14], the
triglyceride and glucose index (TyG) [15], and the trigly-
ceride to high-density lipoprotein cholesterol ratio (TG/
HDL-C) [16]. The use of more than one insulin resistance
index can reflect the effect of different aspects of insulin
resistance in exposure-outcome relationships.
An understanding of the relationship between insulin
resistance indexes and cardiac autonomic function may
improve our understanding of the contribution to cardio-
vascular risk attributed to cardiac autonomic function.
Our goal was to determine the association of insulin re-
sistance indexes with cardiac autonomic function – mea-
sured by 48-h ambulatory electrocardiogram monitoring
– in a population of older adults without diabetes.
Methods
Study population
This study [17] was ancillary to the Atherosclerosis Risk
in Communities (ARIC) Study [18], an ongoing prospect-
ive study of the causes of atherosclerosis and its clinical
outcomes in adults 45 to 64 years of age at recruitment in
1987–1989. This study invited participants from among
those who attended the ARIC Study Visit 5 cohort exam
to attend a brief clinic visit that included placement of a
48-h ambulatory electrocardiogram monitor; the age
range at enrollment was 66 to 89. For this analysis, the ex-
posure and covariates, unless otherwise noted, were mea-
sured at the Visit 5 cohort exam (2011–2013) and the
outcome measure of heart rate variability was measured at
the ancillary study visit (2014–2016). Participants were
selected using a stratified random sampling design to
enrich for African-Americans and risk factors for atrial
fibrillation. Participants were selected from 2 (Forsyth
County, North Carolina and Jackson, Mississippi) of the 4
ARIC field centers; and considered at high risk of atrial
fibrillation if they had a prior hospitalization for heart fail-
ure, reduced ejection fraction (< 50%), or enlarged left
atrial size (left atrial volume index ≥ 32) on echocardiog-
raphy at Visit 5. A total of 1205 participants were included
in the study. This study was approved by the Institutional
Review Boards at the field centers and the Collaborative
Studies Coordinating Center at the University of North
Carolina at Chapel Hill. All participants provided written
informed consent at the visits.
For our analysis, we excluded adults with missing am-
bulatory electrocardiograms due to transmission issues
or dropout (n = 3 and n = 1, respectively); ambulatory
electrocardiograms with > 10% noise or recording time
< 20 h (n = 4); missing medication information at either
visit (n = 4); use of antiarrhythmic medications at either
visit (n = 10); diabetes at Visit 5 or insulin medications at
Visit 5 or insulin medications at the ancillary visit (n =
383); and fasting < 8 h at Visit 5 (n = 41). Insulin resist-
ance indexes ± 3SD from the mean were excluded. After
exclusions, our analytic sample included n = 759 adults
without diabetes. After distribution-based exclusions,
our final analytic sample included n = 727 adults with
HOMA-IR values, n = 749 adults with TyG values, and
n = 750 adults with TG/HDL-C values. See Supplemental
Figure 1 for a flow chart of the exclusions.
Blood collection, processing, and assay
Blood specimens were collected using a standardized
venipuncture protocol, processed within 90 min, and
shipped weekly to central laboratories at Visit 5 [19].
Fasting glucose was assayed using enzymatic methods.
Fasting insulin was assayed using immunoassay methods.
Triglyceride was assayed using enzymatic methods.
High-density lipoprotein cholesterol was assayed using
direct methods. The coefficient of variation was 10.6%
(mean 12.9 μU/mL) for fasting insulin, 3.1% (mean
112.9 mg/dL) for fasting glucose, 4.9% (mean 125.2 mg/
dL) for triglyceride, and 4.2% (mean 51.7 mg/dL) for
high-density lipoprotein cholesterol [20].
Insulin resistance indexes
Insulin resistance indexes were calculated using measures
from Visit 5. The homeostatic model assessment of insulin
resistance (HOMA-IR) was equal to: (fasting glucose in
mg/dL x fasting insulin in μU/mL) / 405. The triglyceride
and glucose index (TyG) was equal to: Ln [(fasting trigly-
ceride in mg/dL x fasting glucose in mg/dL) / 2]. The
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triglyceride to high-density lipoprotein cholesterol ratio
(TG/HDL-C) was equal to: (fasting triglyceride in mg/dL /
fasting high-density lipoprotein cholesterol in mg/dL). The
repeatability of HOMA-IR and TG/HDL-C -- measured as
intraclass correlation coefficients among participants exam-
ined twice, 4–15weeks apart -- was 0.70 for HOMA-IR
and 0.80 for TG/HDL-C [20]. The repeatability of TyG was
not available, but the repeatability of its constituent analytes
-- triglyceride and fasting glucose -- was available; the
short-term repeatability was 0.76 for triglyceride and 0.56
for fasting glucose [20].
Ambulatory electrocardiograms
An ambulatory electrocardiogram monitor (SEER Light Ex-
tend; GE, Milwaukee, WI) was attached using 7 electrodes
in a modified V3 placement using a standardized protocol
at the brief ancillary visit. Participants were instructed to
wear the monitor during usual activities, but to avoid get-
ting it wet and to return it after 48 h. Electrocardiographic
recordings were digitally transferred to, and centrally proc-
essed by, the Epidemiological Cardiology Research Center
at the Wake Forest School of Medicine. Recordings were
analyzed by trained technicians following a standardized
protocol (GE MARS 8.0.2; GE, Milwaukee, Wisconsin).
Heart rate variability
Heart rate variability metrics were derived using 48-h
ambulatory electrocardiography from the ancillary study
visit. Heart rate variability was based on an analysis of
the intervals between successive normal QRS complexes.
Time domain measures included the standard deviation
of normal-to-normal R-R intervals (SDNN), a measure
of total variability; the root mean square of successive
differences in normal-to-normal R-R intervals (RMSSD),
a measure of vagal activity; and the percentage of succes-
sive normal-to-normal R-R intervals that differ by > 50
ms (pNN50), a measure of vagal activity. Frequency
domain measures included the low-frequency spectral
component (LF) from 0.04 to 0.15 Hz, a measure of sym-
pathetic and vagal activity; the high-frequency spectral
component (HF) from 0.15 to 0.4 Hz, a measure of vagal
activity; and the ratio of low frequency to high frequency
(LF/HF), a measure of sympathovagal balance.
Covariates
Participant characteristics were measured using a stan-
dardized protocol at Visit 5 [21]. Blood pressure was
measured using a sphygmomanometer after a five-
minute waiting period; three measurements were taken
and the mean of the last two of three measurements was
used in analyses. Waist circumference was measured
using a measuring tape, at the apex of the iliac crest and
at the end of a normal expiration. Weight was measured
using a digital scale, height was measured using a fixed
stadiometer, and body mass index was calculated as
weight in kilograms divided by height in meters squared.
Former smoker (yes vs no) status and former drinker
(yes vs no) status were ascertained via self-report on
questionnaires. Any prior coronary heart disease was
based on self-report at Visit 1 in 1987–1989, ongoing
surveillance of hospitalizations in the communities, and
hospitalizations that occurred outside the communities
as identified from annual follow-up of participants [18].
Statistical analysis
Participant characteristics were described overall and by
quartiles of insulin resistance indexes. Associations between
the insulin resistance index quartiles and participant char-
acteristics were assessed using ANOVA for continuous var-
iables and the chi-squared test for categorical variables.
Logistic regression with weights for sampling and non-
response was used to estimate odds ratios (OR) and 95%
confidence intervals (95% CI). Insulin resistance indexes
were defined by quartiles. Low heart rate variability was
defined by metrics <25th percentile. The estimates of
association for quartiles 4, 3, and 2 (i.e., the comparison
groups) were compared to quartile 1 (i.e., the referent
group); and the Cochran-Armitage test was used to test
for trend. The estimates are interpreted as the prospect-
ive association of insulin resistance indexes with reduced
cardiac autonomic function.
In the main analysis, age at ancillary visit, sex, and race/
study-site (Jackson site/African-American, Forsyth site/
White, Forsyth site/African-American) were used as covari-
ates because they were considered potential confounders.
In supplemental analysis, any prior coronary heart disease
and systolic blood pressure were used as covariates because
they were considered potential confounders. Additional
analysis was conducted to examine the estimates by race.
Insulin resistance indexes were defined using quartiles
(non-linear terms) and standardized units (linear terms),
then the Akaike information criterion was used to select
for fit of functional form. Because the Akaike informa-
tion criterion indicated the fit was similar for both non-
linear terms and linear terms, non-linear terms were
used for the estimates of association.
We observed an association between insulin resistance
indexes and heart rate variability metrics that were indica-
tive of vagal activity. We decided to further investigate the
relationship between insulin resistance indexes and vagal
activity by including pNN50; and the relationship between
insulin resistance indexes and sympathovagal balance by
including the LF/HF ratio. We defined pNN50 as <25th
percentile and LF/HF as >75th percentile.
Results
The average age was 78 years, 66% (n = 497) were women,
and, per the sampling design, 58% (n = 438) were African
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American. Waist circumference was higher with higher
quartiles of HOMA-IR; the trend was similar by quartiles
of TyG and by quartiles of TG/HDL-C. Systolic blood
pressure was not higher but use of blood pressure medica-
tions was higher with higher quartiles of HOMA-IR
(Table 1); however, the relationship differed by quartiles
of TyG (Supplemental Table 2, Additional file 1) and TG/
HDL-C (Supplemental Table 3, Additional file 1).
High insulin resistance indexes (i.e., Quartile 4 vs
Quartile 1) were not associated with low SDNN, but
were associated with low RMSSD. Low SDNN was as
likely at low insulin resistance indexes as at high insulin
resistance indexes for HOMA-IR, TyG, and TG/HDL-C
(OR: 1.35 (0.80, 2.29), OR: 1.33 (0.82, 2.17), OR: 1.30
(0.78, 2.14)). The test for trend indicated no association
between any of the indexes and low SDNN. Low RMSSD
was more likely at high, as compared to low, insulin re-
sistance indexes for HOMA-IR, TyG, and TG/HDL-C
(OR: 1.68 (1.00, 2.81), OR: 2.03 (1.21, 3.39), and OR:
1.73 (1.01, 2.97), respectively). The test for trend indi-
cated a positive association between the indexes and low
RMSSD. In summary, there was a lack of an association
of insulin resistance indexes with low SDNN, an indica-
tor of total heart rate variability (Fig. 1; Supplemental
Table 1, Additional file 1), but a positive association with
low RMSSD, an indicator of vagal activity (Fig. 2; Sup-
plemental Table 1, Additional file 1).
High insulin resistance indexes (i.e., Quartile 4 vs Quar-
tile 1) were associated with low LF and low HF. Compared
to low insulin resistance indexes, low LF was more likely
at high insulin resistance indexes for HOMA-IR although
not statistically significant, for TyG, and for TG/HDL-C
(OR: 1.69 (0.99, 2.88), OR: 1.98 (1.18, 3.33), and OR: 1.73
(1.02, 2.93), respectively). The test for trend indicated a
positive association between the indexes and low LF.
Compared to low insulin resistance indexes, low HF was
more likely at high insulin resistance indexes for HOMA-
IR, TyG, and TG/HDL-C (OR: 1.90 (1.14, 3.18), OR: 1.98
(1.21, 3.25), and OR: 1.76 (1.07, 2.90), respectively). The
test for trend indicated a positive association between the
indexes and low HF. In summary, there was a positive
association of insulin resistance indexes with low LF,
an indicator of sympathetic and vagal activity (Fig. 3;
Supplemental Table 1, Additional file 1), and with
low HF, an indicator of vagal activity (Fig. 4; Supple-
mental Table 1, Additional file 1).
Adjusting for any prior coronary heart disease and sys-
tolic blood pressure did not substantively alter the esti-
mates. The inferences remained the same (Supplemental
Tables 4 and 5, respectively, Additional file 1). Stratifying
Table 1 Participant characteristics by quartiles of homeostatic model assessment of insulin resistance (HOMA-IR) (Visit 5, 2011–2013)
HOMA-IR
Quartile 1 Quartile 2 Quartile 3 Quartile 4 All P-value
[0.20, 1.73] [1.74, 2.78] [2.79, 4.34] [4.35,16.88]
(n = 181) (n = 182) (n = 182) (n = 182) (n = 727)
Age (years), mean ± SE 78 ± 0.4 78 ± 0.4 77 ± 0.3 77 ± 0.3 78 ± 0.2 < 0.01
Women, n(%) 124 (69) 123 (68) 109 (60) 116 (64) 497 (66) 0.17
African American, n(%) 100 (55) 105 (58) 102 (56) 115 (63) 438 (58) 0.18
Waist circumference (cm),
mean ± SE
89 ± 0.7 95 ± 0.9 100 ± 0.8 106 ± 1 97 ± 0.5 < 0.0001
BMI (kg/m2), mean ± SE 25 ± 0.3 28 ± 0.4 29 ± 0.4 32 ± 0.5 29 ± 0.2 < 0.0001
SBP (mmHg), mean ± SE 129 ± 1.4 129 ± 1.5 128 ± 1.2 128 ± 1.3 129 ± 0.7 0.91
DBP (mmHg), mean ± SE 64 ± 0.9 65 ± 0.8 64 ± 0.7 65 ± 0.8 65 ± 0.4 0.78
Heart rate (beats per minute),
mean ± SE
72 ± 0.6 72 ± 0.7 72 ± 0.6 71 ± 0.7 72 ± 0.3 0.79
Blood pressure medication, n(%) 104 (58) 120 (67) 123 (69) 137 (76) 510 (68) 0.02
Prior CHD, n(%) 16 (9) 25 (14) 20 (11) 27 (15) 91 (12) 0.16
Current smoker, n(%) 14 (8) 7 (4) 12 (7) 6 (3) 39 (5) 0.13
Current drinker, n(%) 60 (36) 60 (35) 56 (32) 54 (30) 238 (33) 0.22
Former smoker, n(%) 56 (36) 84 (54) 87 (54) 82 (50) 325 (49) 0.02
Former drinker, n(%) 48 (28) 62 (36) 65 (37) 67 (37) 258 (36) 0.09
Fasting glucose (mg/dL),
mean ± SE
95 ± 0.7 102 ± 0.7 105 ± 0.6 108 ± 0.7 103 ± 0.4 < 0.0001
Insulin (μU/mL), mean ± SE 5 ± 0.1 9 ± 0.1 13 ± 0.2 24 ± 0.6 13 ± 0.3 < 0.0001
Participant characteristics were described overall and by quartiles of insulin resistance indexes. Continuous variables were described using ANOVA and categorical
variables were described using the chi-squared test
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by race did not indicate heterogeneity by race. The infer-
ences remained the same (Supplemental Tables 6 and 7,
Additional file 1). We did not observe an association be-
tween the insulin resistance indexes with pNN50 or with
LF/HF (Supplemental Table 8, Additional file 1).
Discussion
We examined the relationship between insulin resistance
and cardiac autonomic function measured during daily
activities using ambulatory electrocardiography record-
ings in older adults in a large population-based cohort
study. We observed the estimates were not robust for all
measures of insulin resistance with all measures of
cardiac autonomic function, but were robust with mea-
sures of cardiac autonomic function indicative of vagal
activity. As such, higher insulin resistance indexes were
associated with reduced cardiac autonomic function --
consistently and specifically -- for indicators of vagal
activity.
Prior studies reported on the relationship between in-
sulin resistance that used fasting insulin and heart rate
variability. A prior study of middle age adults without
diabetes showed an inverse relationship between insulin
and SDNN, as well as between insulin and RMSSD using
2-min electrocardiography recordings (n = 8971) [11]. A
similar study showed an inverse relationship between
Fig. 1 Association of insulin resistance indexes with low SDNN in adults without diabetes. Abbreviations: HOMA-IR, homeostatic model
assessment of insulin resistance; TyG, triglyceride and glucose index; TG/HDL-C, triglyceride to high-density lipoprotein cholesterol ratio; SDNN,
standard deviation of normal-to-normal R-R intervals. Comments: HOMA-IR quartiles are equal to: [0.20, 1.73], [1.74, 2.78], [2.79, 4.34], and [4.35,
16.88]. TyG quartiles are equal to: [7.25, 8.24], [8.25, 8.54], [8.55, 8.81], and [8.82, 9.93]. TG/HDL-C quartiles are equal to: [0.45, 1.29], [1.30, 1.95], [1.96,
2.74], and [2.75, 9.30]. Low SDNN (<25th percentile) is equal to < 97 ms. Estimates are adjusted for age at ancillary visit, sex, and race/study-site
Fig. 2 Association of insulin resistance indexes with low RMSSD in adults without diabetes. Abbreviations: HOMA-IR, homeostatic model
assessment of insulin resistance; TyG, triglyceride and glucose index; TG/HDL-C, triglyceride to high-density lipoprotein cholesterol ratio; RMSSD,
root mean square of successive differences in normal-to-normal R-R intervals. Comments: HOMA-IR quartiles are equal to: [0.20, 1.73], [1.74, 2.78],
[2.79, 4.34], and [4.35, 16.88]. TyG quartiles are equal to: [7.25, 8.24], [8.25, 8.54], [8.55, 8.81], and [8.82, 9.93]. TG/HDL-C quartiles are equal to: [0.45,
1.29], [1.30, 1.95], [1.96, 2.74], and [2.75, 9.30]. Low RMSSD (<25th percentile) is equal to < 21 ms. Estimates are adjusted for age at ancillary visit,
sex, and race/study-site
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insulin and HF using 2-min electrocardiography recordings
(n = 1779) [12]. Finally, a previous study of adults without
diabetes showed an inverse association of log insulin (and
log-HOMA-IR) with SDNN, RMSSD, log LF, and log HF
using 24-h electrocardiography recordings (n = 94) [22].
Whereas prior studies defined cardiac autonomic dysfunc-
tion as the exposure, our study instead defined insulin
resistance as the exposure (i.e., insulin resistance as an ante-
cedent to cardiac autonomic dysfunction) [23]. Compared
to studies with electrocardiography recordings measured at
rest, we report similar inferences using ambulatory record-
ings measured during daily activities. Our findings suggest
that the effect, reduced regulation (variation) of heart rate,
is sustained, on average, over time.
We investigated the role of other metrics of heart rate
variability. We did not observe a relationship between the
insulin resistance indexes with vagal activity defined by
pNN50. This result may be because the meaning of this
metric may depend on the attributes of the study popula-
tion and length of monitoring [24]; as such, we observed a
relationship with some but not all metrics of vagal activity.
We did not observe a relationship between the insulin re-
sistance indexes with sympathovagal imbalance defined by
LF/HF. This result may be because this metric can depend
Fig. 3 Association of insulin resistance indexes with low LF in adults without diabetes. Abbreviations: HOMA-IR, homeostatic model assessment of
insulin resistance; TyG, triglyceride and glucose index; TG/HDL-C, triglyceride to high-density lipoprotein cholesterol ratio; LF, low frequency.
Comments: HOMA-IR quartiles are equal to: [0.20, 1.73], [1.74, 2.78], [2.79, 4.34], and [4.35, 16.88]. TyG quartiles are equal to: [7.25, 8.24], [8.25, 8.54],
[8.55, 8.81], and [8.82, 9.93]. TG/HDL-C quartiles are equal to: [0.45, 1.29], [1.30, 1.95], [1.96, 2.74], and [2.75, 9.30]. Low LF (<25th percentile) is equal
to < 7.59 Hz. Estimates are adjusted for age at ancillary visit, sex, and race/study-site
Fig. 4 Association of insulin resistance indexes with low HF in adults without diabetes. Abbreviations: HOMA-IR, homeostatic model assessment
of insulin resistance; TyG, triglyceride and glucose index; TG/HDL-C, triglyceride to high-density lipoprotein cholesterol ratio; HF, high frequency.
Comments: HOMA-IR quartiles are equal to: [0.20, 1.73], [1.74, 2.78], [2.79, 4.34], and [4.35, 16.88]. TyG quartiles are equal to: [7.25, 8.24], [8.25, 8.54],
[8.55, 8.81], and [8.82, 9.93]. TG/HDL-C quartiles are equal to: [0.45, 1.29], [1.30, 1.95], [1.96, 2.74], and [2.75, 9.30]. Low HF (<25th percentile) is equal
to < 10.97 Hz. Estimates are adjusted for age at ancillary visit, sex, and race/study-site
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on the make-up of its component metrics [25]. Because the
relationship between sympathetic activity and parasympa-
thetic activity is non-reciprocal (i.e., not mutual), this metric
may not always be an accurate representation of sympatho-
vagal balance.
Insulin has been shown to regulate sympathetic and para-
sympathetic activity [26–31]. In insulin sensitive adults, the
response to insulin is a shift from sympathetic activity to
parasympathetic activity, whereas in insulin resistant adults,
the response is limited (i.e., less in increment) [29]. This ef-
fect may be attributed to reduced response of the sinoatrial
node to sympathetic and parasympathetic activity [30]. In-
sulin resistance may thus contribute to cardiac autonomic
dysfunction, in the absence of diabetes.
Our study should be considered in the context of its
strengths and limitations. We assessed insulin resistance
with insulin resistance indexes instead of standard refer-
ence measures such as the euglycemic hyperinsulinemic
clamp. Although there is a link in the dysregulation of
glucose, insulin, and lipids in insulin resistance, the role
of lipids may be affected by or influenced by pathways
independent of insulin resistance [32]. However, prior
studies have indicated a strong correlation of HOMA-IR
(r = − 0.820) [14], TyG (r = − 0.681) [15], and TG/HDL-C
(r = 0.60) [16] with direct measures of insulin mediated
glucose uptake. We observed that the statistical signifi-
cance of the estimates varied indicating that the esti-
mates of association may not be robust with respect to
HOMA-IR, TyG, and TG/HDL-C. However, although
the statistical significance of the estimates may be dis-
similar, the magnitude and direction of the estimates are
similar for HOMA-IR, TyG, and TG/HDL-C, suggesting
a consistent relationship in our study. Our strengths in-
clude the use of a cohort that is well-characterized and a
focus on adults without diabetes.
The relationship between insulin resistance and cardiac
autonomic function is important for public health; insulin
resistance can be modified through lifestyle changes. Insulin
resistance often precedes the development of diabetes [33]
that has been shown to be associated with cardiac dysinner-
vation [34]. Insulin resistance itself may contribute to car-
diac autonomic dysfunction. Because insulin resistance can
be improved with lifestyle-based interventions, it is an im-
portant target for primary prevention [6].
Conclusions
In summary, higher levels of insulin resistance indexes
were associated with reduced cardiac autonomic func-
tion -- consistently and specifically for indicators of
vagal activity – measured during daily activities in older
adults without diabetes, using ambulatory electrocardio-
graphic monitoring in a large population-based study.
Primary prevention of insulin resistance may reduce the
risk of cardiac autonomic dysfunction.
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